Edward White
Stock Analyst at HC Wainwright & Co.
(2.09)
# 2,856
Out of 4,755 analysts
363
Total ratings
31.81%
Success rate
-1.63%
Average return
Main Sectors:
Stocks Rated by Edward White
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
VALN Valneva SE | Reiterates: Buy | $18 | $7.83 | +129.89% | 33 | Feb 5, 2025 | |
ACET Adicet Bio | Reiterates: Neutral | n/a | $0.90 | - | 21 | Feb 5, 2025 | |
CGEM Cullinan Therapeutics | Maintains: Buy | $28 → $33 | $9.81 | +236.39% | 22 | Jan 29, 2025 | |
SABS SAB Biotherapeutics | Reiterates: Buy | $6 | $1.65 | +263.64% | 14 | Jan 29, 2025 | |
LRMR Larimar Therapeutics | Reiterates: Buy | $15 | $3.15 | +376.19% | 6 | Jan 24, 2025 | |
IFRX InflaRx | Reiterates: Buy | $8 | $2.52 | +217.46% | 23 | Jan 16, 2025 | |
TGTX TG Therapeutics | Reiterates: Buy | $55 | $31.11 | +76.79% | 30 | Jan 15, 2025 | |
KPTI Karyopharm Therapeutics | Reiterates: Buy | $7 | $0.60 | +1,070.37% | 26 | Jan 15, 2025 | |
DVAX Dynavax Technologies | Maintains: Buy | $29 → $31 | $12.70 | +144.09% | 20 | Jan 14, 2025 | |
INZY Inozyme Pharma | Maintains: Buy | $14 → $16 | $1.29 | +1,140.31% | 12 | Jan 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.62 | - | 9 | Jan 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.47 | +754.34% | 5 | Jan 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $4.36 | +152.29% | 16 | Dec 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $3.72 | +437.63% | 1 | Dec 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.76 | +153.62% | 19 | Dec 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $10.42 | +63.10% | 13 | Dec 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $3.23 | +519.20% | 17 | Dec 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $15.01 | +239.77% | 28 | Dec 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $7.73 | +184.61% | 4 | Nov 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.47 | - | 11 | Nov 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $7.66 | - | 1 | Oct 24, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $5 | $2.34 | +113.68% | 9 | Oct 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.28 | - | 12 | Jun 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.65 | - | 1 | Nov 8, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $0.67 | +4,108.63% | 3 | Aug 30, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $21.38 | +40.32% | 5 | Aug 11, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $1.21 | +891.74% | 2 | Mar 6, 2018 |
Valneva SE
Feb 5, 2025
Reiterates: Buy
Price Target: $18
Current: $7.83
Upside: +129.89%
Adicet Bio
Feb 5, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.90
Upside: -
Cullinan Therapeutics
Jan 29, 2025
Maintains: Buy
Price Target: $28 → $33
Current: $9.81
Upside: +236.39%
SAB Biotherapeutics
Jan 29, 2025
Reiterates: Buy
Price Target: $6
Current: $1.65
Upside: +263.64%
Larimar Therapeutics
Jan 24, 2025
Reiterates: Buy
Price Target: $15
Current: $3.15
Upside: +376.19%
InflaRx
Jan 16, 2025
Reiterates: Buy
Price Target: $8
Current: $2.52
Upside: +217.46%
TG Therapeutics
Jan 15, 2025
Reiterates: Buy
Price Target: $55
Current: $31.11
Upside: +76.79%
Karyopharm Therapeutics
Jan 15, 2025
Reiterates: Buy
Price Target: $7
Current: $0.60
Upside: +1,070.37%
Dynavax Technologies
Jan 14, 2025
Maintains: Buy
Price Target: $29 → $31
Current: $12.70
Upside: +144.09%
Inozyme Pharma
Jan 13, 2025
Maintains: Buy
Price Target: $14 → $16
Current: $1.29
Upside: +1,140.31%
Jan 10, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.62
Upside: -
Jan 10, 2025
Reiterates: Buy
Price Target: $4
Current: $0.47
Upside: +754.34%
Dec 30, 2024
Reiterates: Buy
Price Target: $11
Current: $4.36
Upside: +152.29%
Dec 30, 2024
Initiates: Buy
Price Target: $20
Current: $3.72
Upside: +437.63%
Dec 23, 2024
Reiterates: Buy
Price Target: $7
Current: $2.76
Upside: +153.62%
Dec 13, 2024
Reiterates: Buy
Price Target: $17
Current: $10.42
Upside: +63.10%
Dec 10, 2024
Reiterates: Buy
Price Target: $20
Current: $3.23
Upside: +519.20%
Dec 10, 2024
Reiterates: Buy
Price Target: $51
Current: $15.01
Upside: +239.77%
Nov 14, 2024
Reiterates: Buy
Price Target: $22
Current: $7.73
Upside: +184.61%
Nov 13, 2024
Reiterates: Neutral
Price Target: n/a
Current: $0.47
Upside: -
Oct 24, 2024
Initiates: Neutral
Price Target: n/a
Current: $7.66
Upside: -
Oct 14, 2024
Maintains: Buy
Price Target: $15 → $5
Current: $2.34
Upside: +113.68%
Jun 4, 2024
Reiterates: Neutral
Price Target: n/a
Current: $0.28
Upside: -
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $1.65
Upside: -
Aug 30, 2021
Initiates: Buy
Price Target: $28
Current: $0.67
Upside: +4,108.63%
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $21.38
Upside: +40.32%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $1.21
Upside: +891.74%